🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8760
-0.4340 (-33.13%)
At close: Nov 20, 2026, 4:00 PM EST
0.8620
-0.0140 (-1.60%)
After-hours: Nov 20, 2026, 7:40 PM EST

PMV Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
19.9937.9840.8837.71108.3172.47
Short-Term Investments
82.5774.96128.58165.35132.76124.7
Cash & Short-Term Investments
102.56112.94169.45203.06241.05297.16
Cash Growth
-20.65%-33.35%-16.55%-15.76%-18.88%-17.78%
Prepaid Expenses
2.332.286.23.535.133.3
Restricted Cash
---0.820.820.82
Total Current Assets
104.89115.23175.66207.41247.01301.29
Property, Plant & Equipment
0.261.041.5519.0520.4913.15
Long-Term Investments
5.96-13.8425.512.516.91
Other Long-Term Assets
0.290.30.240.190.310.22
Total Assets
111.4116.56191.29252.15270.31331.57

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.643.166.583.2433.19
Accrued Expenses
8.917.867.449.947.318.63
Current Portion of Leases
0.140.40.350.850.530.4
Total Current Liabilities
10.6911.4214.3714.0310.8312.22
Long-Term Leases
-0.440.8412.4313.4510.79
Other Long-Term Liabilities
43.61-----
Total Liabilities
54.311.8515.2126.4624.2823.01

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Additional Paid-In Capital
574.21551.08544.65535.47487.52476.36
Retained Earnings
-516.95-446.45-368.71-310-241.04-167.73
Comprehensive Income & Other
-0.160.080.140.22-0.45-0.08
Total Common Equity
57.11104.71176.08225.69246.03308.56
Shareholders' Equity
57.11104.71176.08225.69246.03308.56
Total Liabilities & Equity
111.4116.56191.29252.15270.31331.57

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.140.841.1913.2913.9811.19
Net Cash (Debt)
108.38112.11182.11215.28229.57302.88
Net Cash Growth
-15.54%-38.44%-15.41%-6.23%-24.20%-16.20%
Net Cash Per Share
1.922.133.534.485.046.71
Filing Date Shares Outstanding
75.5353.3351.9351.4445.7745.45
Total Common Shares Outstanding
75.5353.3351.9451.4545.7745.43
Working Capital
94.21103.81161.29193.38236.17289.07
Book Value Per Share
0.761.963.394.395.386.79
Tangible Book Value
57.11104.71176.08225.69246.03308.56
Tangible Book Value Per Share
0.761.963.394.395.386.79
Machinery
1.451.481.823.172.532.28
Leasehold Improvements
0.040.080.0510.770.410.16
SEC Filings: 10-K · 10-Q